Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04364620
Title AB-16B5 Combined With Docetaxel in Subjects With Metastatic Non-Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Alethia Biotherapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Hôpital Maisonneuve-Rosemont Montréal Quebec H1T 2M4 Canada Details
Centre Hospitalier de l'Université de Montréal (CHUM) Montréal Quebec H2X 3E4 Canada Details
Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ) Québec Quebec G1V 4G5 Canada Details
Centre Intégré de Santé et de Services Sociaux des Laurentides (Hôpital Régional de St-Jérôme) Saint-Jérôme Quebec J7Z 5T3 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field